|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CHOLESTECH CORPORATION, 10-K405, EX-23.1, 2000-06-28 |
Next: CELLEGY PHARMACEUTICALS INC, 8-K, 2000-06-28 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> MAR-31-2000
<PERIOD-START> MAR-28-1999
<PERIOD-END> MAR-31-1999
<CASH> 6,959
<SECURITIES> 2,850
<RECEIVABLES> 2,059
<ALLOWANCES> 220
<INVENTORY> 3,714
<CURRENT-ASSETS> 17,264
<PP&E> 15,368
<DEPRECIATION> 7,059
<TOTAL-ASSETS> 32,218
<CURRENT-LIABILITIES> 5,742
<BONDS> 0
0
0
<COMMON> 71,959
<OTHER-SE> (45,483)
<TOTAL-LIABILITY-AND-EQUITY> 32,218
<SALES> 27,422
<TOTAL-REVENUES> 27,422
<CGS> 11,084
<TOTAL-COSTS> 24,647
<OTHER-EXPENSES> 319
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 3,261
<INCOME-TAX> 129
<INCOME-CONTINUING> 3,132
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 3,132
<EPS-BASIC> 0.27
<EPS-DILUTED> 0.26
</TABLE>
|
|